HIT Consultant July 12, 2023
Jasmine Pennic

What You Should Know:

  • Prenosis, Inc., a Chicago, IL-based AI company enabling precision medicine in acute care, announced today that it has been awarded two Phase 2 SBIR grants totaling $4.8M in funding by the National Institute of General Medical Sciences (NIGMS), a division of the National Institute of Health (NIH).
  • The grants will study the use of Prenosis’s Immunix™ Artificial Intelligence platform for acute immune states. Prenosis has built a collection of artificial...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Investments, Pharma / Biotech, Precision Medicine, Technology, Trends
Related Articles:
Generative AI Is Helping To Clear Up Brain Fog
Getting started with AI agents (part 1): Capturing processes, roles and connections
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
5 questions for the Abundance Institute's Neil Chilson
AI agents are unlike any technology ever

Share This Article